Adlai Nortye Ltd. (ANL)
NASDAQ·Healthcare·Biotechnology
$10.36
+7.02%
Mkt Cap $274.57M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$26.00
Range $20.00 – $32.00
Implied Upside
+151.0%
Consensus $26.00 vs current $10.36
NASDAQ·Healthcare·Biotechnology
$10.36
+7.02%
Mkt Cap $274.57M
No recent rating data.
Price Target (4 analysts)
$26.00
Range $20.00 – $32.00
+151.0%
Consensus $26.00 vs current $10.36